Incyte (INCY) is a publicly traded Healthcare sector company. As of July 5, 2026, INCY trades at $116.86 with a market cap of $23.35B and a P/E ratio of 43.77. INCY moved +2.68% today. Year to date, INCY is +18.15%; over the trailing twelve months it is +71.42%. Its 52-week range spans $53.56 to $118.69. Analyst consensus is buy with an average price target of $112.94. Rallies surfaces INCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for INCY, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $116.86 |
| Market Cap | $23.35B |
| P/E Ratio | 43.77 |
| EPS | $2.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $118.69 |
| 52-Week Low | $53.56 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.70B |
| Net Income | $597.60M |
| Gross Margin | 93.10% |
20 analysts cover INCY: 0 strong buy, 9 buy, 11 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $112.94.